Dr. Reddy’s Laboratories launched Sugammadex Injection Single-Dose Vials, a generic equivalent of Bridion, in the United States (US). Sugammadex Injection is a vertically integrated product manufactured through Dr. Reddy’s global supply network. Dr. Reddy’s launch of the product is on the first day of generic availability in the United States, a release said.Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adult and pediatric patients aged 2 years and older undergoing surgery.The Bridion brand (100mg/ml) had U.S. sales of approximately $1.6 billion for the latest 12-month period endedMay 2026, according to IQVIA National Sales Perspectives data.Bridion is a registered trademark of Merck Sharp & Dohme B.V.Published on August 4, 2026